Patent ID: 11202673

Abstract:
A non-invasive electrodynamic radiative electroporation system and method for safe in vivo delivery of specific radiant energy to physiologically inaccessible sites for selective destruction of biomolecular function of virions, particularly Covid-19 and its variants. The system and method applies a computer or like controller to generate, modulate, direct and deliver applied external electric fields from plural antennas to target tissues in the full respiratory tract, including lung microstructures, cardiovascular tissues and neuron networks. Electric fields exceeding a critical threshold-value interact with the virus lipid bilayer membranes, intra-membrane organelles, mRNA, and biomolecular scaffold assemblies, to destroy virion function through irreversible electroporation and electropermeabilization. Polarized electric fields are generated to provide force vectors in optimal dynamic angular distribution to the virion membrane surface and modulated within time-scales short compared to thermal transport characteristic times to effect the electroporation as an adiabatic process that preempts Joule heating of normal tissues.